United Kingdom

Sarepta Therapeutics Inc (SRPT.OQ)

SRPT.OQ on NASDAQ Stock Exchange Global Select Market

15 Feb 2019
Change (% chg)

$3.57 (+2.65%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

M. Kathleen Behrens

65 2015 Independent Chairwoman of the Board

Douglas Ingram

55 2017 President, Chief Executive Officer, Director

Sandesh Mahatme

53 2017 Executive Vice President, Chief Financial Officer and Chief Business Officer

Guriqbal Basi

61 2017 Senior Vice President, Chief Scientific Officer

David Howton

46 2012 Senior Vice President, General Counsel, Corporate Secretary